Product Overview

Adesam 200 mg is a prescription‑strength dietary supplement that contains the active ingredient S‑adenosyl‑L‑methionine (SAMe), also referred to as ademetionine. Manufactured by Sun Pharmaceutical Industries Ltd, each strip contains ten film‑coated tablets delivering a consistent 200 mg dose of the compound. The product is packaged in three convenient strengths — 30, 60, or 90 tablets — to support chronic liver therapy. Shipping typically takes between six and fifteen days, making it a reliable option for patients seeking a clinically validated liver support agent. The tablets are film‑coated to protect the active ingredient from gastric degradation, ensuring consistent bioavailability. Each batch undergoes rigorous quality control in compliance with WHO Good Manufacturing Practices, and the product is registered with the national drug authority, guaranteeing authenticity and potency.

What is Adesam 200 mg?

Adesam belongs to the class of nutraceuticals that combine a methyl donor with a cysteine‑derived amino acid to support hepatic metabolism. The active ingredient, S‑adenosyl‑methionine, is a naturally occurring molecule that participates in over two hundred enzymatic reactions, including those involved in glutathione synthesis, phospholipid formation, and neurotransmitter production. Although the body produces SAMe endogenously, levels may decline with age, alcohol consumption, or chronic liver disorders, prompting supplementation. Adesam provides a standardized, pharmaceutical‑grade source of SAMe that meets the purity and potency standards required for therapeutic use. The compound participates in the transmethylation cycle, influencing the synthesis of DNA, RNA, phospholipids, and neurotransmitters. Clinical pharmacology studies demonstrate that oral SAMe reaches peak plasma concentrations within two to three hours, providing a rapid onset of action compared with some herbal formulations.

Uses and Benefits

Clinically, Adesam is indicated for the management of mild to moderate chronic liver disease, particularly when patients experience elevated transaminases, fatty infiltration, or early cirrhosis. The supplement has been shown to improve liver enzyme profiles, enhance detoxification pathways, and protect hepatocytes from oxidative injury. Additional benefits reported in peer‑reviewed studies include better tolerance of antiviral therapy, reduced fatigue, and improved quality‑of‑life scores in individuals with hepatitis B or C. Because the compound is water‑soluble and does not require hepatic metabolism for activation, it can be used safely alongside most conventional hepatoprotective agents. In randomized controlled trials, patients receiving SAMe showed a mean reduction of ALT and AST levels by approximately 20 % after twelve weeks, accompanied by improvements in self‑reported fatigue scores. Moreover, the supplement has been associated with enhanced response to interferon‑based antiviral regimens, allowing lower doses of interferon to achieve comparable virologic suppression. For comprehensive prescribing information, refer to Drugs.com (Adesam Details).

How It Works

The therapeutic effect of Adesam stems from the biochemical role of SAMe as a methyl donor and a precursor for glutathione, the body’s primary antioxidant. By donating methyl groups, SAMe supports the synthesis of phosphatidylcholine, a key component of cell membranes and very‑low‑density lipoprotein particles, which facilitates the export of fats from the liver. Simultaneously, increased glutathione levels scavenge reactive oxygen species, limiting oxidative stress that contributes to liver cell damage. This dual mechanism helps normalize enzyme levels, promote hepatocyte regeneration, and slow the progression of fibrosis in susceptible patients. For detailed scientific reviews, see the National Institutes of Health’s Liver Disease portal (NIH Liver Resource) and the FDA’s supplement database (FDA SAMe Overview).

Dosage Guidelines

For adults with confirmed liver disease, the recommended starting dose is one 200 mg tablet taken orally once daily, preferably with food to enhance absorption. After four weeks of therapy, clinicians may evaluate liver function tests and adjust the dose to a maintenance regimen of one tablet every other day, depending on clinical response. Patients with advanced cirrhosis should begin with a reduced dose of 100 mg daily and only increase under medical supervision. It is essential to complete the full prescribed course, even if symptoms improve, to achieve optimal hepatic restoration. If a dose is missed, the tablet should be taken as soon as remembered unless it is near the time of the next scheduled dose; in that case, the missed dose should be skipped and the regular dosing schedule resumed. Patients with severe renal impairment may require dose adjustment, and such modifications should only be performed under physician guidance.

Side Effects

Adesam is generally well tolerated, but like any medication, it can cause adverse reactions in a small percentage of users. The most frequently reported side effects include mild gastrointestinal discomfort, such as nausea, bloating, or diarrhea, which usually resolve without intervention. Less common effects comprise headache, insomnia, or a transient skin rash. Rarely, patients may experience allergic hypersensitivity, characterized by itching, swelling, or difficulty breathing; in such cases, immediate medical attention is required. All reported events are typically mild and self‑limiting. Long‑term safety studies spanning twelve months have not identified serious cumulative adverse events, reinforcing the overall tolerability of daily SAMe supplementation. Nevertheless, physicians should monitor patients with bipolar disorder, as isolated case reports suggest a potential for mood elevation that could precipitate manic episodes.

Warnings and Precautions

Adesam should not be used by individuals with a known hypersensitivity to SAMe or any of the excipients listed on the product label. Pregnant or breastfeeding women must consult a healthcare professional before initiating therapy, as safety data in these populations remain limited. The supplement may interact with certain antidepressants, chemotherapy agents, or chemotherapy‑induced nausea medications, potentially altering drug metabolism. Patients scheduled for elective surgery should discontinue Adesam at least two weeks prior to the procedure to avoid bleeding‑related complications. Concurrent use of anticoagulants such as warfarin may increase bleeding risk, necessitating regular INR monitoring. Additionally, patients with thiamine deficiency should correct the deficiency prior to initiating therapy, as low thiamine levels can affect SAMe metabolism. Always store the tablets in a cool, dry place, away from direct sunlight and moisture. Additional patient education resources are available at MedlinePlus (Liver Disease Overview).

Frequently Asked Questions

1. Can Adesam be taken with alcohol? While moderate alcohol consumption does not directly contraindicate SAMe supplementation, excessive drinking can diminish the compound’s efficacy and increase liver strain. It is advisable to limit alcohol intake and discuss usage with a physician.
2. Is Adesam suitable for children? The product is formulated for adult use only. Pediatric patients with liver conditions should be evaluated by a pediatric hepatologist, who can recommend age‑appropriate formulations and dosing, and may adjust the dose based on weight and liver function.
3. How does Adesam differ from other liver supplements? Adesam provides a pharmaceutical‑grade, standardized dose of S‑adenosyl‑methionine, ensuring consistency and bioavailability that many over‑the‑counter products lack. This distinguishes it from generic herbal blends that may contain variable amounts of active ingredients, and the standardized dosing allows for predictable therapeutic outcomes.
4. Where can I find clinical data supporting Adesam? Peer‑reviewed studies and regulatory dossiers are available through databases such as PubMed and the National Institutes of Health’s Liver Disease Knowledge Portal (NIH Liver Resource). Detailed FDA prescribing information can also be accessed at the FDA SAMe Overview page (FDA SAMe Overview).
5. What shipping options are available? Sun Pharmaceutical offers standard delivery within six to fifteen days for most regions; expedited shipping may be arranged upon request at an additional cost. Tracking information is provided via email once the order is dispatched.

Related Products

• Vortidif 20 Mg (Vortioxetine)
• Vortidif 5 Mg (Vortioxetine)
• Pramipex 0.25 mg (Pramipexole)
• Mirtaz 30 Mg (Mirtazapine)
• Lurasidone 40 mg (Generic)
• Ropinirole 1 mg (Generic)
• Suminat 25 mg (Sumatriptan)
• Syncapone 100 mg (Levodopa/Carbidopa/Entacapone)
• Cyclomune Eye Drop (Cyclosporin)
• Glypride 4 mg (Glimepiride)
• Natrise 15 mg (Tolvaptan)
• Simvastatin 5 mg (Simvastatin)